Bioterminology - - BioPharm International

ADVERTISEMENT

Bioterminology

BioPharm International Supplements


PTC Points to Consider; PTC documents are not regulations with the force of law, but are instead guidelines on issues that FDA believes should be considered by regulated industry. These documents are not definitive or all-inclusive. In fact, they are presented as drafts subject to further modification, and readers are invited to submit comments. They acknowledge that processes and associated knowledge change with time. They suggest and recommend procedures that manufacturers should consider during development of new drugs and biologics.

purification A central part of downstream processing that takes a crude fermentation supernatant or cell homogenate (a chaotic slurry of tissues and cells) and isolates the product from it in a fairly pure form.

pyrogen Any fever-inducing (pyrogenic) substance; more specifically, a lipopolysaccharide (the major constituents of the cell walls of Gram-negative bacteria). The major endogenous pyrogen in mammals is probably interleukin-1, production of which is stimulated by lipopolysaccharide.

pyrogenic endotoxins Components of bacteria (such as lipopolysaccharides) that induce a feverish immune response in higher organisms.

Q-R

QA Quality assurance; 1. The quality systems and processes used to control every step of pharmaceutical manufacturing to ensure that the product meets all of its specifications and quality attributes, and that all steps were done and documented in compliance with cGMP. 2. The sole work unit that is empowered to disposition drug product and drug substance (release or reject) for use in humans; and that provides and sustains quality systems such as document control, corrective and preventive actions, audits and oversight.

QC Quality control; 1. the system of testing that confirms and measures the quality of raw materials, process intermediates, final product and environmental samples, during ongoing production as well as during start-up and validation. 2. The work unit that usually performs testing regulated under cGMP and evaluates results against specifications, action limits, or targets, and makes technical recommendations to QA. May be in the same department as QA in some organizations.

Qtof A hybrid mass spectrometer design that couples time-of-flight (TOF) instrument with a quadrupole. This pairing results in a combination of performance characteristics: accurate mass measurement, the ability to carry out fragmentation experiments, and high quality quantitation.

quadrupole mass analyzer One type of mass analyzers used in mass spectrometry. It consists of four circular rods, set perfectly parallel to each other. Ions are separated in a quadrupole based on the stability of their trajectories in the oscillating electric fields that are applied to the rods, thus filtering the sample ions based on their mass-to-charge ratio.

qualification 1. Documenting that a piece of equipment does what it was designed to do, was installed correctly, and continues to operate within specified parameters over time. 2. A term used during process or analytical development to describe the experiments that are done prior to validation of the assay or process, that define the critical parameters and design space. 3. Analytical instruments are qualified to ensure fitness for intended use (USP <1058>). See also DQ, IQ, OQ, PQ. This term sometimes is used interchangeably with "validation."

quality The suitability of either a drug substance or drug product for its intended use. This term includes such attributes as the identity, strength, and purity (from ICH Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances). [From ICH Q8]

Quality by Design (QbD) A term defined by the ICH quality guidelines, meaning the use of science, engineering, and statistical tools, as appropriate, to design quality into a process or product, or device; and to 'mistake-proof' or design out common errors.

quality risk management A systematic process for the assessment, control, communication and review of risks to the quality of the drug (medicinal) product across the product lifecycle. [From ICH Q9]


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International Supplements,
Click here